← Every company

Sarepta Therapeutics Inc Lobbying

What Sarepta Therapeutics Inc discloses spending to lobby Congress, and who it pays to do it. Every lobbying firm files quarterly under the Lobbying Disclosure Act, naming its client, its fee and the issues it worked.

SRPT on carbonthat →
Disclosed spend
$830K
across every filing on file
Filings
6
Years covered
1
Firms retained
3

What it lobbies about

Health IssuesMedical/Disease Research/Clinical LabsBudget/AppropriationsScience/TechnologyTrade (domestic/foreign)Medicare/Medicaid

6 filings

Newest year first, and within a year the largest fee first — a filing period is a word rather than a date, so it cannot order itself.

PeriodLobbying for themDisclosed
20261st Quarter (Jan 1 - Mar 31)SAREPTA THERAPEUTICS, INC.Health IssuesScience/Technology$270K
20262nd Quarter (Apr 1 - June 30)SAREPTA THERAPEUTICS, INC.Budget/AppropriationsHealth Issues$220K
20261st Quarter (Jan 1 - Mar 31)MICHAEL BEST STRATEGIES LLCHealth IssuesMedical/Disease Research/Clinical Labs$110K
20262nd Quarter (Apr 1 - June 30)TARPLIN, DOWNS & YOUNG, LLCBudget/AppropriationsHealth Issues$90K
20261st Quarter (Jan 1 - Mar 31)TARPLIN, DOWNS & YOUNG, LLCBudget/AppropriationsHealth Issues$90K
20262nd Quarter (Apr 1 - June 30)MICHAEL BEST STRATEGIES LLCHealth IssuesMedical/Disease Research/Clinical Labs$50K

A filing reports either the fee paid to a lobbying firm or what a company spent lobbying for itself, never both, so the total is a sum of the two. The client is named as filed, which is often a subsidiary. Lobbying is lawful, disclosed and extremely common — the figure is context, not an accusation.

More on SRPT

Related datasets